VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $46,747,000 | +4.0% | 356,300 | 0.0% | 2.50% | +1.7% |
| Q2 2014 | $44,937,000 | -4.3% | 356,300 | 0.0% | 2.46% | -21.3% |
| Q1 2014 | $46,971,000 | +12.3% | 356,300 | 0.0% | 3.13% | +4.3% |
| Q4 2013 | $41,830,000 | +14.6% | 356,300 | +1.8% | 3.00% | -1.5% |
| Q3 2013 | $36,516,000 | +21.2% | 350,000 | 0.0% | 3.05% | -3.9% |
| Q2 2013 | $30,128,000 | – | 350,000 | – | 3.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |